Europe Analytical Laboratory Services Market, By Test Type (Bioanalytical Testing, Batch Release Testing, Stability Testing, Raw Material Testing, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring), Service Type (Hospital-Based Laboratories, Stand-Alone Laboratories and Clinics-Based Laboratories), Method Type (Cell-Based Assays, Virology Testing, Biomarker Testing, Pharmacokinetic Testing, Immunogenicity and Serology), Application (Oncology, Neurology, Infectious disease, Gastroenterology, Cardiology and Other Applications), Technology (Mass Spectroscopy (LC-MS/MS), Immunochemistry, UPLC Technology, Turbulent Flow Technology, Others), End User Channel (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, Contract Research Organizations and Others) -Industry Trends and Forecast to 2029.
Europe Analytical Laboratory Services Market Analysis and Size
A number of analytical services are provided in the market, such as bioanalytical testing, raw material testing, batch release testing, product validation, physical characterization and others. These services are widely employed in the healthcare sector, including pharmaceutical companies, biopharmaceutical companies and medical device companies. These services provide a reliable source for accuracy, quality and efficiency. They have applications in areas such as oncology, neurology, infectious diseases, cardiology and others. The Europe analytical laboratory services market is growing with the rise in government initiatives to strengthen analytical testing capabilities and the growing number of drug approvals and clinical trials. Moreover, rising usage and development of a large number of macromolecules and biosimilar for various therapeutic areas and increased spending by governments to set up new laboratories are other factors accelerating the laboratory services market growth.
Data Bridge Market Research analyses that the Europe analytical laboratory services market is expected to reach USD 3,743.48 million by 2029, at a CAGR of 14.8% during the forecast period. The bioanalytical testing segment accounts for the largest offering segment in the Europe analytical laboratory services market. The Europe analytical laboratory services market report also covers pricing analysis, patent analysis, and technological advancements in depth.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customisable 2019-2014)
|
|
Quantitative Units
|
Revenue in USD Million, Pricing in USD
|
|
Segments Covered
|
By Test Type (Bioanalytical Testing, Batch Release Testing, Stability Testing, Raw Material Testing, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring), Service Type (Hospital-Based Laboratories, Stand-Alone Laboratories and Clinics-Based Laboratories), Method Type (Cell-Based Assays, Virology Testing, Biomarker Testing, Pharmacokinetic Testing, Immunogenicity and Serology), Application (Oncology, Neurology, Infectious disease, Gastroenterology, Cardiology and Other Applications), Technology (Mass Spectroscopy (LC-MS/MS), Immunochemistry, UPLC Technology, Turbulent Flow Technology, Others), End User Channel (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, Contract Research Organizations and Others)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Ireland, Turkey and rest of Europe
|
|
Market Players Covered
|
Eurofins Scientific, Q2 Solutions (a subsidiary of IQVIA), SGS SA, SOLVIAS AG, Syneos Health, ICON plc, BioAgilytix Labs, Pharmaceutical Research Associates Inc., ALS Limited, Covance (a subsidiary of Laboratory Corporation of America Holdings), Intertek Group plc, Evotec SE, Charles River Laboratories, Medpace, WuXi AppTec, and PPD Inc. (a subsidiary of Thermo Fisher Scientific Inc.) among others
|
Market Definition
Analytical laboratory services are concerned with a wide range of chemical and microbiological assays. Analytical laboratory services include method development and validation, sample analysis for concentration confirmation, purity, homogeneity, and stability assays on preliminary formulations and finalized drug products for IND, NDA, and ANDA submissions. Analytical services, also referred to as "materials testing," is used to describe various techniques used to identify the chemical makeup or characteristics of a particular sample. Manufacturers in industries such as pharmaceuticals, food, electronics, and plastics often use analytical testing for reverse engineering or failure analysis and identifying contaminants or stains on products
Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
-
Growing expenditure on drugs and medical devices
The rise of pharmaceutical and biotechnological industries will increase the market for these analytical services as they are dependent on drug markets to provide services such as pharmacokinetic testing and other batch testing and microbial testing. Therefore, it is expected to act as a driver for the growth of the Europe analytical laboratory services market in the forecast period.
-
Government initiatives to strengthen analytical testing capabilities
Government funding and initiative to expand the analytical services will help the market grow and increase the market players in the forecast period. This is expected to increase the market size and act as a driver for the growth of the Europe analytical laboratory services market in the forecast period.
-
Increasing number of drug approvals and clinical trials
The market players give the analytical testing process under contract research. Furthermore, the increasing biopharmaceutical industry with increased drug production and research for novel products is expected to act as a driver for the growth of the Europe analytical laboratory services market in the forecast period.
Opportunities
-
Increasing collaboration among market players
Collaborations in the market is the primary factor that is expected to create opportunities in the market. Agreements, partnerships, and collaborations are performed to overcome hurdles such as limited Europe presence and supply chain and to increase the service portfolio. In the Europe analytical laboratory services market, various market players have performed this, creating opportunities in the market.
Restraints/Challenges
- High cost setting of an advanced analytical lab
The considerable investment needed to set up a bioanalytical facility with a limited and highly efficient instrument is expected to limit the market growth due to high investment costs. This is expected to act as a restraint on the growth of the Europe analytical laboratory services market in the forecast period.
COVID-19 Impact on Europe Analytical Laboratory Services Market
COVID-19 created a major impact on various industries as almost every country has opted for the shutdown of every facility except the ones dealing in the essential goods. The government took some strict actions, such as the shutdown of facilities and sale of non-essential goods, blocked international trade and many more, to prevent the spread of COVID-19. The only business dealing with this pandemic situation were the essential services allowed to open and run the processes.
COVID-19 has impacted the market of analytical laboratory services negatively. Due to the cancellation of the clinical trial, the demand for analytical services was also disrupted. The major portion of these analytical services comes from the clinical trials and CRO, which get badly impacted. However, some of the market players, such as Eurofins Scientific, which can provide analytical support, were successful in minimizing the loss during COVID-19. The supply chain was disrupted as the material and solvent that were mandatory for these analytical testing faced challenges in the customs department and were not allowed to cross international borders.
Hence, COVID-19 has negatively impacted the analytical testing business, but the strategic initiative of the market players is somehow gaining success in minimizing the loss in the net revenue or segmental revenue.
Recent Developments
- In February 2021, Eurofins Scientific announced that they had acquired Beacon Discovery, preeminent drug discovery and contract research organization (CRO). This will increase the company's access to contract research and will increase its revenue for the company
- In April 2021, SGS SA announced that the company SYNLAB Analytics & Services is now be called SGS Analytics which is due to the acquisition of the leading European environmental, food & health sciences testing and tribology services company. The acquisition will continue growth and innovation by helping businesses to comply with ever increasing regulations designed to ensure food, pharmaceutical, and environmental safety
Europe Analytical Laboratory Services Market Scope
The Europe analytical laboratory services market is segmented on the basis of test type, service type, method type, application, technology, and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
By Test Type
- Bioanalytical testing
- Batch release testing
- Method validation
- Raw material testing
- Microbial testing
- Physical characterization
- Stability testing
- Environmental monitoring
On the basis of test type, the Europe analytical laboratory services market is segmented into bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing and environmental monitoring.
By Service Type
- Hospital-based laboratories
- Stand-alone laboratories
- Clinics-based laboratories
On the basis of service type, the Europe analytical laboratory services market is segmented into hospital-based laboratories, stand-alone laboratories and clinic-based laboratories.
By Method Type
- Pharmacokinetic testing
- Biomarker testing
- Virology testing
- Cell-based assays
- Immunogenicity
- Serology
On the basis of method type, the Europe analytical laboratory services market is segmented into cell-based assays, virology testing, biomarker testing, pharmacokinetic testing, immunogenicity and serology.
By Application
- Oncology
- Neurology
- Infectious diseases
- Cardiology
- Gastroenterology
- Others
On the basis of application, the Europe analytical laboratory services market is segmented into oncology, neurology, infectious diseases, gastroenterology, cardiology and other applications.
By Technology
- Mass spectroscopy
- Immunochemistry
- UPLC technology
- Turbulent flow technology
- Others
On the basis of technology, the Europe analytical laboratory services market is segmented into mass spectroscopy, immunochemistry, UPLC technology, turbulent flow technology and others.
By End-User
- Pharmaceutical and biopharmaceutical companies
- Contract development and manufacturing organizations
- Contract research organizations
- Others
On the basis of end user, the Europe analytical laboratory services market is segmented into pharmaceutical & biopharmaceutical industries, contract development & manufacturing organizations, contract research organizations and others.
Europe Analytical Laboratory Services Market Regional Analysis/Insights
The Europe analytical laboratory services market is analysed, and market size insights and trends are provided by country, test type, service type, method type, application, technology, and end user as referenced above.
The countries covered in the Europe analytical laboratory services market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Ireland, Turkey and rest of Europe.
Germany is likely to be the fastest-growing Europe Analytical laboratory services market due to the increasing biopharmaceutical industry with increased drug production.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing a forecast analysis of the country data.
Competitive Landscape and Europe Analytical Laboratory Services Market Share Analysis
The Europe analytical laboratory services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the Europe analytical laboratory services market.
Some of the major companies providing analytical laboratory services in the Europe analytical laboratory services market are Eurofins Scientific, Q2 Solutions (a subsidiary of IQVIA), SGS SA, SOLVIAS AG, Syneos Health, ICON plc, BioAgilytix Labs, Pharmaceutical Research Associates Inc., ALS Limited, Covance (a subsidiary of Laboratory Corporation of America Holdings), Intertek Group plc, Evotec SE, Charles River Laboratories, Medpace, WuXi AppTec, and PPD Inc. (a subsidiary of Thermo Fisher Scientific Inc.) among others
SKU-